Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans

Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc

(2014) Toshihiro Kai et al.   PLoS One

MafB promotes atherosclerosis by inhibiting foam-cell apoptosis

(2014) Michito Hamada et al.   Nature Communications

Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice

(2013) Song-iee Han et al.   HEPATOLOGY

Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases

(2013) Satoko Arai et al.   Seminars in Immunopathology

Obesity-Associated Autoantibody Production Requires AIM to Retain the Immunoglobulin M Immune Complex on Follicular Dendritic Cells

(2013) Satoko Arai et al.   Cell Reports

Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes

(2012) Yoshihiro Iwamura et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

17β-Estradiol enhances response of mice spleen B cells elicited by TLR9 agonist

(2012) Yixin Xu et al.   CELLULAR IMMUNOLOGY

Molecular Mechanisms of Estrogen Receptors' Suppression of Lipogenesis in Pancreatic β-Cells

(2012) Joseph P. Tiano et al.   ENDOCRINOLOGY

Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

(2012) György Baffy et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic Steatohepatitis and Noncirrhotic Hepatocellular Carcinoma: Fertile Soil

(2012) Dawn Torres et al.   SEMINARS IN LIVER DISEASE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

AIMing at Metabolic Syndrome

(2011) Toru Miyazaki et al.   CIRCULATION JOURNAL

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

(2010) Eek Joong Park et al.   CELL

Macrophage-Derived AIM Is Endocytosed into Adipocytes and Decreases Lipid Droplets via Inhibition of Fatty Acid Synthase Activity

(2010) Jun Kurokawa et al.   Cell Metabolism

NF-κB and STAT3 – key players in liver inflammation and cancer

(2010) Guobin He et al.   CELL RESEARCH

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

(2010) Brad Q. Starley et al.   HEPATOLOGY

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

(2010) Judith Ertle et al.   INTERNATIONAL JOURNAL OF CANCER

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review

(2010) Yoshitaka Takuma   WORLD JOURNAL OF GASTROENTEROLOGY

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

(2009) Joe Gray et al.   BMC CANCER

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?

(2009) A.L. Chagas et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers

(2009) Won Kon Kim et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

(2009) Valérie Paradis et al.   HEPATOLOGY

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

(2009) Natsuko Kawada et al.   JOURNAL OF GASTROENTEROLOGY

17β-Estradiol Enhances the Response of Plasmacytoid Dendritic Cell to CpG

(2009) Xiaoxi Li et al.   PLoS One

Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice

(2008) Galyna Bryzgalova et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM